In gastric cancer, it was suggested that the MET amplification is often accompanied by human epidermal growth factor receptor 2 (HER2) overexpression, and co-expression of MET and HER2 can synergistically enhance tumor invasion, and metastasis, which is a crucial factor for poor prognosis 18. Here, ERBB2 is linked to gastric cancer.